ImpediMed Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
10,812.00
32,582.00
82,254.00
54,884.00
31,345.00
Total Accounts Receivable
445.00
633.00
3,507.00
3,804.00
4,306.00
Inventories
1,132.00
1,638.00
1,378.00
1,465.00
1,811.00
Other Current Assets
351.00
265.00
510.00
1,102.00
338.00
Total Current Assets
12,740.00
35,118.00
87,649.00
61,255.00
37,800.00
Net Property, Plant & Equipment
203.00
298.00
396.00
518.00
368.00
Total Investments and Advances
50.00
93.00
48.00
158.00
95.00
Intangible Assets
1,965.00
2,408.00
2,477.00
2,412.00
3,504.00
Total Assets
14,958.00
37,917.00
90,570.00
64,343.00
41,767.00
Accounts Payable
350.00
1,131.00
1,828.00
2,142.00
1,765.00
Income Tax Payable
199.00
-
-
-
-
Other Current Liabilities
787.00
1,845.00
3,373.00
3,327.00
3,898.00
Total Current Liabilities
1,336.00
2,976.00
5,201.00
5,469.00
5,663.00
Provision for Risks & Charges
90.00
104.00
115.00
77.00
102.00
Total Liabilities
1,426.00
3,080.00
5,316.00
5,546.00
5,765.00
Common Equity (Total)
13,532.00
34,837.00
85,254.00
58,797.00
36,002.00
Total Shareholders' Equity
13,532.00
34,837.00
85,254.00
58,797.00
36,002.00
Total Equity
13,532.00
34,837.00
85,254.00
58,797.00
36,002.00
Liabilities & Shareholders' Equity
14,958.00
37,917.00
90,570.00
64,343.00
41,767.00

About ImpediMed

View Profile
Address
50 Parker Court
Pinkenba Queensland (QLD) 4008
Australia
Employees -
Website http://www.impedimed.com
Updated 07/08/2019
ImpediMed Ltd. engages in the development and distribution of medical devices using bioimpedance spectroscopy technologies for use in the non-invasive clinical assessment and monitoring of human disorders and diseases. It operates through the Medical and Test and Measurement segments. The Medical segment supplies non-invasive medical devices to two under-served markets: aiding in the subclinical assessment of individuals at risk of secondary lymphoedema; and the monitoring of body composition and hydration.